Actively Recruiting
Multi-model Image of Doxycycline in TAO
Led by Sun Yat-sen University · Updated on 2023-11-22
20
Participants Needed
1
Research Sites
256 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the efficacy of doxycycline treating Thyroid Associated Ophthalmopathy by multi-modal image.
CONDITIONS
Official Title
Multi-model Image of Doxycycline in TAO
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provided informed consent
- Age between 18 and 70 years old
- Diagnosed with Thyroid Associated Ophthalmopathy (TAO)
You will not qualify if you...
- Sight-threatening TAO with dysthyroid optic neuropathy
- Allergy to tetracycline
- Contraindications for MRI such as metal pacemaker, fake teeth, foreign body, or other materials interfering with the scan
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhongshan Ophthalmic Center
Guangzhou, Guangdong, China
Actively Recruiting
Research Team
D
Dan Liang
CONTACT
Y
Yuxi Chen
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here